SBIR/STTR Research Award
Economical Soy-Isoflavone Production
Award amount
$105,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- FERMALOGIC, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Commercial applications for soy isoflavones
have grown significantly in recent years. This is fueled by research revealing
the potential health benefits of diets containing soy products and increasing
interest in functional foods. Much of the benefit in soyfoods is thought to
come from the isoflavone component of the soybean. In order to introduce
isoflavones into the American diet, food manufacturers are offering ordinary
foods supplemented with isoflavones. Therefore there is a need by health food
producers for natural sources of isoflavone concentrates or extracts. We have
identified a source for an isoflavone extract coming from an existing bacterial
fermentation used for the production of erythromycin. This fermentation process
would generate highly purified isoflavones in large quantities if the producing
organism were altered to inactivate the genes that cause isoflavones in the
growth medium to degrade during the fermentation. This modification to the
organism would be technically simple to perform once the genes are identified.
In Phase I we propose to characterize the isoflavone degradation pathway. In
Phase II we propose to find the degradation genes and inactivate them, thus
creating isoflavones as an added value product of the erythromycin
fermentation.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported